• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOLTON MEDICAL, INC. RELAY PRO NBS THORACIC STENT-GRAFT SYSTEM; STENT, ENDOVASCULAR GRAFT, AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOLTON MEDICAL, INC. RELAY PRO NBS THORACIC STENT-GRAFT SYSTEM; STENT, ENDOVASCULAR GRAFT, AORTIC Back to Search Results
Catalog Number 28-N4-46-209-46U
Device Problem Material Invagination (1336)
Patient Problems Stenosis (2263); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/15/2023
Event Type  malfunction  
Event Description
"unable to fully deploy the stent-graft: the peripheral relay pro stent-graft (28-n4-40-154-36u) was first deployed from 3 cm proximal to the celiac artery and successfully implanted.The relay pro stent-graft concerned was then deployed from zone 4 and placed proximally to the first stent-graft.Final angiogram revealed that the proximal relay pro stent-graft was deformed and had not expanded to the intended diameter.Careful balloon modeling did not improve the situation.A cone-beam ct scan confirmed that infolding had occurred in the proximal two stents.As no blood flow into the aneurysm was observed, the procedure was completed.Physician's comment.A large device was implanted in a narrow portion of the blood vessel, resulting in infolding.Operation type: tevar blood loss: unknown.No image available no pre-case plan available additional information may be obtained upon request tc (b)(4)" patient outcome: "no damage to the patient's health.".
 
Manufacturer Narrative
Bolton medical, inc.(d/b/a terumo aortic), herein known as the "company", is submitting this report pursuant to 21 cfr part 803, has made reasonable efforts to obtain complete information, and has provided as much as is available to the company as of the submission date of this report.This report is based on information obtained by the company, which may not have been able to fully investigate or verify prior to the date the report was required by the regulations.Any required fields that are unpopulated are blank because the information is currently unknown, unavailable, or not applicable.This report does not constitute an admission or a conclusion by anyone that the device caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the certain regulations, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Manufacturer Narrative
Bolton medical, inc.(d/b/a terumo aortic), herein known as the "company", is submitting this report pursuant to 21 cfr part 803, has made reasonable efforts to obtain complete information, and has provided as much as is available to the company as of the submission date of this report.This report is based on information obtained by the company, which may not have been able to fully investigate or verify prior to the date the report was required by the regulations.Any required fields that are unpopulated are blank because the information is currently unknown, unavailable, or not applicable.This report does not constitute an admission or a conclusion by anyone that the device caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the certain regulations, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
"unable to fully deploy the stent-graft: the peripheral relay pro stent-graft (28-n4-40-154-36u) was first deployed from 3 cm proximal to the celiac artery and successfully implanted.The relay pro stent-graft concerned was then deployed from zone 4 and placed proximally to the first stent-graft.Final angiogram revealed that the proximal relay pro stent-graft was deformed and had not expanded to the intended diameter.Careful balloon modeling did not improve the situation.A cone-beam ct scan confirmed that infolding had occurred in the proximal two stents.As no blood flow into the aneurysm was observed, the procedure was completed.Physician's comment.A large device was implanted in a narrow portion of the blood vessel, resulting in infolding.Operation type: tevar.Blood loss: unknown.No image available.No pre-case plan available.Additional information may be obtained upon request (tc#(b)(4))".Patient outcome: "no damage to the patient's health.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RELAY PRO NBS THORACIC STENT-GRAFT SYSTEM
Type of Device
STENT, ENDOVASCULAR GRAFT, AORTIC
Manufacturer (Section D)
BOLTON MEDICAL, INC.
799 international parkway
sunrise FL 33325
Manufacturer Contact
megan indeglia
799 international parkway
sunrise, FL 33325
9548389699
MDR Report Key18508052
MDR Text Key333348463
Report Number2247858-2024-00005
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P200045
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/12/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/09/2024
Device Catalogue Number28-N4-46-209-46U
Device Lot Number2202010188
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received12/15/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/09/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-